SINO BIOPHARMACEUTICAL earnings per share and revenue

1177 earnings per share for the last semiannual are 0.03 HKD whereas the estimation was 0.09 HKD which accounts for -62.50% surprise. Company revenue for the same period amounts to 13.83 B HKD despite the estimated figure of 15.07 B HKD. Estimated earnings per share for the next semiannual are 0.11 HKD, and revenue is expected to reach 18.44 B HKD. Also watch annual changes over time to get a bigger picture of 1177 earnings per share and revenue dynamics.